Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
94.28
+1.12 (1.20%)
Dec 5, 2025, 4:00 PM EST - Market closed
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $2.00B in the quarter ending September 30, 2025, with 9.71% growth. This brings the company's revenue in the last twelve months to $8.01B, up 5.47% year-over-year. In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth.
Revenue (ttm)
$8.01B
Revenue Growth
+5.47%
P/S Ratio
2.34
Revenue / Employee
$471,229
Employees
17,000
Market Cap
18.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
| Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
| Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
| Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
| Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ZBH News
- 11 days ago - Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman - GlobeNewsWire
- 15 days ago - Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm - GlobeNewsWire
- 17 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 18 days ago - Could Zimmer Biomet Stock Be Your Next Buy? - Forbes
- 21 days ago - Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology - PRNewsWire
- 4 weeks ago - Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London - PRNewsWire
- 4 weeks ago - Time To Buy Zimmer Biomet Stock? - Forbes
- 4 weeks ago - Zimmer Biomet Holdings, Inc. (ZBH) Q3 2025 Earnings Call Transcript - Seeking Alpha